Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Tempo Scan Pacific Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.730 (kapitalisasi pasar 12,36 T, volume 24 jam 1,41 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 74,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (1,41 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 12,36 T |
Volume | 324 rb | 1,41 jt |
Lot | 3,24 rb | 14,08 rb |
Perputaran | 77,68 jt | 3,83 M |
Harga Rata-rata | 239,75 | 2.722,04 |
Nilai Transaksi | 77,68 jt | 3,83 M |
Harga Ekuilibrium Indikatif | 240 | 2.730 |
Volume Ekuilibrium Indikatif | 1 | 2,51 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →